Gregory Braden to Muromonab-CD3
This is a "connection" page, showing publications Gregory Braden has written about Muromonab-CD3.
Connection Strength
0.011
-
Madden RL, Mulhern JG, Benedetto BJ, O'Shea MH, Germain MJ, Braden GL, O'Shaughnessy J, Lipkowitz GS. Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients. Transpl Int. 2000; 13(5):344-50.
Score: 0.011